Multiple ROC curves indicated that plasma Tau could more accurately identify participants in different groups (aMCI vs. non-MCI: 0.6909; AD vs. non-MCI: 0.7993; AD vs. aMCI: 0.6698). The gene discussed is MAPT; the disease is Alzheimer disease.